Your browser doesn't support javascript.
loading
The Diagnostic Utility of Holter Monitoring in Catecholaminergic Polymorphic Ventricular Tachycardia.
Naderi, Borna; Davies, Brianna; Khan, Habib; Sanatani, Shubhayan; Andrade, Jason G; Bennett, Matthew T; Hawkins, Nathaniel M; Chakrabarti, Santabhanu; Yeung-Lai-Wah, John A; Deyell, Marc W; Laksman, Zachary W M; Roston, Thomas M; Krahn, Andrew D.
Affiliation
  • Naderi B; Centre for Cardiovascular Innovation, St. Paul's and Vancouver General Hospitals, University of British Columbia, Vancouver, British Columbia, Canada.
  • Davies B; Centre for Cardiovascular Innovation, St. Paul's and Vancouver General Hospitals, University of British Columbia, Vancouver, British Columbia, Canada.
  • Khan H; Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Western University, London, Ontario, Canada.
  • Sanatani S; British Columbia Children's Hospital, Vancouver, British Columbia, Canada.
  • Andrade JG; Centre for Cardiovascular Innovation, St. Paul's and Vancouver General Hospitals, University of British Columbia, Vancouver, British Columbia, Canada.
  • Bennett MT; Centre for Cardiovascular Innovation, St. Paul's and Vancouver General Hospitals, University of British Columbia, Vancouver, British Columbia, Canada.
  • Hawkins NM; Centre for Cardiovascular Innovation, St. Paul's and Vancouver General Hospitals, University of British Columbia, Vancouver, British Columbia, Canada.
  • Chakrabarti S; Centre for Cardiovascular Innovation, St. Paul's and Vancouver General Hospitals, University of British Columbia, Vancouver, British Columbia, Canada.
  • Yeung-Lai-Wah JA; Centre for Cardiovascular Innovation, St. Paul's and Vancouver General Hospitals, University of British Columbia, Vancouver, British Columbia, Canada.
  • Deyell MW; Centre for Cardiovascular Innovation, St. Paul's and Vancouver General Hospitals, University of British Columbia, Vancouver, British Columbia, Canada.
  • Laksman ZWM; Centre for Cardiovascular Innovation, St. Paul's and Vancouver General Hospitals, University of British Columbia, Vancouver, British Columbia, Canada.
  • Roston TM; Centre for Cardiovascular Innovation, St. Paul's and Vancouver General Hospitals, University of British Columbia, Vancouver, British Columbia, Canada.
  • Krahn AD; Centre for Cardiovascular Innovation, St. Paul's and Vancouver General Hospitals, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: akrahn@mail.ubc.ca.
Article in En | MEDLINE | ID: mdl-39207284
ABSTRACT

BACKGROUND:

Holter monitoring may raise suspicion of an underlying catecholaminergic polymorphic ventricular tachycardia (CPVT) diagnosis. Although not a primary investigation for CPVT, Holter monitoring is ubiquitously used as a diagnostic tool in the heart rhythm clinic.

OBJECTIVES:

The objective of this study was to explore Holter monitoring in CPVT diagnosis.

METHODS:

This retrospective cohort study analyzed off-therapy Holter monitoring from 13 ryanodine receptor 2-positive CPVT and 34 healthy patients from the Canadian Hearts in Rhythm Organization national registry. Using the Edwards method, the ratio of ambient-maximum heart rate during Holter monitoring was correlated with exertion level to separate premature ventricular contractions (PVCs) during periods of adrenergic and nonadrenergic stress. A receiver operating characteristic curve analysis determined the optimal threshold for isolating CPVT-induced PVCs during adrenergic states.

RESULTS:

PVC burden differed between groups (P = 0.001) but was within population norm, suggesting ambient PVCs are uncommon in CPVT. CPVT patients had higher PVC counts than healthy controls (P = 0.002), with a different distribution based on adrenergic state. The optimal threshold for separating PVCs into periods of adrenergic and nonadrenergic stress in CPVT patients was 76% of the maximum heart rate during the monitoring period. Compared with healthy controls, CPVT patients had a higher PVC count, limited to periods of adrenergic stress, defined by >76% maximum heart rate threshold (P = 0.002; area under the receiver operating characteristic curve 0.84). Below this threshold, there was no significant PVC difference (P = 0.604).

CONCLUSIONS:

Holter monitor PVC counts alone are inadequate for CPVT diagnosis, owing to the adrenergic nature of the disease. Quantifying PVC prevalence at a heart rate threshold >76% identified CPVT with moderate sensitivity (69%) and high specificity (94%).
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JACC Clin Electrophysiol / JACC Clin. Electrophysiol / JACC. Clinical electrophysiology (Online) Year: 2024 Document type: Article Affiliation country: Canada Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JACC Clin Electrophysiol / JACC Clin. Electrophysiol / JACC. Clinical electrophysiology (Online) Year: 2024 Document type: Article Affiliation country: Canada Country of publication: United States